Ivacaftor 25 mg | 98.00%
TargetMol
Ivacaftor (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively.
More Information Supplier PageIvacaftor
Search Results
Norgestrel 200 mg | 99.79%
TargetMol
Norgestrel is a synthetic progestin commonly used alone or in combination with an estrogen for contraception. Norgestrel suppresses the secretion of luteinizing and follicle-stimulating hormones (LH and FSH), thickens cervical mucus, and slows the transit of ova through the fallopian tubes.
More Information Supplier PageNorgestrel
Spebrutinib 2 mg | 97.14%
TargetMol
Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
More Information Supplier PageSpebrutinib
Spebrutinib 25 mg | 97.14%
TargetMol
Spebrutinib is an orally bioavailable, selective inhibitor of Bruton’s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
More Information Supplier PageSpebrutinib
IRAK-1-4 Inhibitor I 2 mg | 100.00%
TargetMol
IRAK-1-4 Inhibitor I
HMN-214 25 mg | Purity Not Available
TargetMol
HMN-214 (IVX-214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
More Information Supplier PageHMN-214
HMN-214 2 mg | Purity Not Available
TargetMol
HMN-214 (IVX-214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
More Information Supplier PageHMN-214
LY 303511 100 mg | 99.91%
TargetMol
LY303511, an inactive analogue of LY294002, is a mTOR inhibitor and no inhibition for PI3-K.
More Information Supplier PageLY 303511
TG6-10-1 25 mg | 100.00%
TargetMol
TG6-10-1
TG6-10-1 2 mg | 100.00%
TargetMol
TG6-10-1